Abstract
The family of insulin-like growth factor binding proteins (IGFBPs) can affect cell proliferation by modulating the availability and bioactivity of insulin-like growth factors (IGFs), or by mechanisms independent of IGFs. To understand better the role(s) of IGFBPs in prostate growth and malignancy, we examined the regulation of IGFBPs in PC-3 cells, a human prostatic adenocarcinoma epithelial cell line that is androgeninsensitive. Both transforming growth factor-β (TGF-β) and retinoic acid (RA), known inhibitors of cellular proliferation, significantly changed the IGFBP profile in PC-3 cells. In cells that were treated with transforming growth factor β-2 (TGF-β2) (0.5–10 ng/mL), IGFBP-3, and IGFBP-5 protein and mRNA increased in a time-and dose-dependent manner. At 10 ng/mL TGF-β, IGFBP-3, and IGFBP-5 protein concentrations were 14- and 9-fold, respectively, over that of controls. Cells treated with Ra (0–1 μM) also showed a time- and dose-dependent increase in IGFBP-3 protein and mRNA levels. However, in contrast to TGF-β2, high concentrations of RA (1 μM) negatively regulated IGFBP-5 expression, with IGFBP-5 mRNA levels downregulated to 20% of that of the control, and protein levels were decreased by 50%. Since both TGF-β and RA increased IGFBP-3 expression and both are known to inhibit prostate cell growth, we speculate that the inhibition of growth is mediated, at least in part, by IGFBP-3.
Similar content being viewed by others
References
Boring, C., Squires, T., and Tong, T. (1993).CA Cancer J. Clin. 43, 7–26.
Henderson, B. E., Ross, R. K., and Pike, M. C. (1991).Science 254, 1131–1138.
Gittes, R. (1991).N. Engl. J. Med. 324, 236–245.
Kim, S.-J., Romeo, D., Yoo, Y. D., and Park, K. (1994).Horm. Res. 42, 5–8.
Jacobs, S., and Story, M. (1988).Prostate 13, 79–87.
Nishi, N., Matuo, Y., Kumitomi, K., Takenada, I., Usami, M., Kotaka, T., and Wada, F. (1988).Prostate 13, 39–48.
Djakiew, D., Delsite, R., Pflug, B., Wrathall, J., Lynch, J., and Onoda, M. (1991).Cancer Res. 51, 3304–3310.
Cohen, P., Peehl, D. M., and Rosenfeld, R. (1991).J. Clin. Endocrinol. Metab. 73, 401–407.
Connolly, J. M., and Rose, D. P. (1994).Prostate 24, 167–175.
Iwamura, M., Sluss, P. M., Casamento, J. B., and Cockett, A. T. (1993).Prostate 22, 243–252.
Kaicer, E., Blat, C., Impenotte, J., Troalen, F., Cuwenot, O., Calvo, F., and Harel, L. (1993).Growth Regulation 3, 180–189.
Shimasaki, S. and Ling, N. (1991).Prog. Growth Factor Res. 3(4), 243–266.
Swisshelm, K., Ryan, K., Tsuchiya, K., and Sager, R. (1995).Proc. Natl. Acad. Sci. USA 92, 4472–4476.
Oh, Y., Nagalla, S. R., Yamanaka, Y., Kim, H.-S., Wilson, E., and Rosenfeld, R. G. (1996).J. Biol. Chem. 82, 301–303.
Clemmons, D., Cascieri, M., Camacho-Hubner, C., McCusker, R., and Bayne, M. (1990).J. Biol. Chem. 265, 1216–1220.
Ross, M., Francis, G., Szabo, L., Wallace, J., and Ballard, J. (1989).Biochem. J. 258, 267–272.
Elgin, R., Busby, W., and Clemmons, D. (1987).Proc. Natl. Acad. Sci. USA 84, 3254–3258.
Gucev, Z. S., Oh, Y., Kelley, K. M., and Rosenfeld, R. G. (1996).Cancer Res. 56, 1545–1550.
Oh, Y., Muller, H. L., Lamson, G., and Rosenfeld, R. G. (1993).J. Biol. Chem. 268, 14,964–14,971.
Huynh, H., Yang, X., and Pollak, M. (1996).J. Biol. Chem. 27, 1016–1021.
Mohan, S., Nakao, Y., Honda, Y., Landale, E., Leser, U., Dony, C., Alng, K., and Baylink, D. J. (1995).J. Biol. Chem. 270, 20,424–20,431.
Oh, Y., Muller, H. L., Ng, L., and Rosenfeld, R. G. (1995).J. Biol. Chem. 270(23), 13,589–13,592.
Cohen, P., Peehl, D. M., Stamey, T. A., Wilson, K. F., Clemmons, D. R., and Rosenfeld, R. G. (1993).J. Clin. Endocrinol. Metab. 76, 1031–1035.
Tennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S., and Plymate, S. R. (1996).J. Clin. Endocrinol. Metab. 81(1), 411–420.
Tennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S., and Plymate, S. R. (1996).J. Clin. Endocrinol. Metab. 81, 3783.
Cohen, P., Graves, H., Peehl, D., Kamerei, M., Giudice, L., and Rosenfeld, R. (1992).J. Clin. Endocrinol. Metab. 75, 1046–1053.
Plymate, S. R., Rosen, C. J., Paulsen, C. A., Ware, J. L., Chen, J., Vessella, R. E., and Birnbaum, R. S. (1996).J. Clin. Endocrin. Metab. 81, 618–624.
Eastham, J., Truong, L., Rogers, E., Kattan, M., Flanders, K., Scardino, P., and Thompson, T. (1995).Lab. Invest. 73(5), 628–635.
Timme, T., Truong, L., Slawin, K., Kadmon, D., Park, S., and Thompson, T. (1995),Microscopy Res. Tech. 30(4), 333–341.
Pasquali, D., Thaller, C., and Eichele, G. (1996).J. Clin. Endocrinol. Metab. 81(6), 2186–2191.
Kaighn, M., Narayan, K., Ohnuki, Y., Lechner, J., and Jones, L. (1979).Invest. Urol. 17, 16–23.
Matsumoto, T., Gargosky, S. E., Oh, Y., and Rosenfeld, R. G. (1996).J. Endocrinol. 148, 355–369.
Duan, C., Hawes, S. B., Prevette, T., and Clemmons, D. R. (1996).J. Biol. Chem. 271(8), 4280–4288.
Sheikh, M. S., Shao, Z.-M., Hussain, A., Clemmons, D. R., Chen, J.-C., Charles T., Roberts, J., LeRoith, D., and Fontana, J. A. (1993).J. Cell. Physiol. 155, 556–567.
Leyen, S. A.-v., Hembree, J. R., and Eckert, R. L. (1994).J. Cell. Physiol. 160, 265–274.
Bang, Y.-J., Kim, S.-J., Danielpour, D., O'Reilly, M. A., Kim, K. Y., Myers, C. E., and Trepel, J. B. (1992).Proc. Natl. Acad. Sci. USA 89, 3536–3560.
Carruba, G., Leake, R. E., Rinaldi, F., Chalmers, D., Comito, L., Sorci, C., Pavone-Macaluso, M., and Castagnetta, L. A. (1994).Steroids 59, 412–420.
Jarrard, D., Blitz, B., Smith, R., Patai, B., and Rukstalis, D. (1994).Prostate 24(1), 46–53.
Angelloz-Nicoud, P. and Binoux, M. (1995).Endocrinology 136(12), 5485–5492.
Lamson, G., Giudice, L., and Rosenfeld, R. (1991).J. Clin. Endocrinol. Metab. 72, 1391–1393.
Canalis, E., and Gabbitas, B. (1995).J. Biol. Chem. 270(18), 10,771–10,776.
McCuster, R. H., and Clemmons, D. R. (1994).Endocrinology 134, 2095–2102.
Zhou, Y., Mohan, S., Linkhart, T. A., Baylink, D. J., and Strong, D. D. (1996).Endocrinology 137(3), 975–983.
Shemer, J., Yaron, A., Werner, H., Shao, Z., Sheikh, M., Fontana, J., Leroith, D., and Robert, C. (1993).J. Clin. Endocrinol. Metab. 77, 1246–1250.
Fontana, J. A., Burrows-Mezu, A., Clemmons, D. R., and LeRoith, D. (1991).Endocrinology 128(2), 1115–1122.
Danielpour, D., Kadomatsu, K., Anzano, M., Smith, J., and Sporn, M. (1994).Cancer Res. 54, 3413–3421.
Oh, Y., Muller, H. L., Pham, H., and Rosenfeld, R. G. (1993). J. Biol. Chem.268(35), 26,045–26,048.
Guenette, R., and Tenniswood, M. (1994).Biochem. Cell Biol. 72, 553–559.
Van-Obberghen-Schilling, E., and Pouyssegur, J. (1983).Exp. Cell Biol. 151, 207–214.
Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., and Binoux, M. (1986).Anal. Biochem. 154, 138–143.
Gargosky, S. E., Pham, H. M., Wilson, K. F., Liu, F., Giudice, L. C., and Rosenfeld, R. G. (1992).Endocrinology 131(6), 3051–3060.
Lamson, G., Oh, Y., Pham, H., Giudice, L., and Rosenfeld, R. (1989).J. Clin. Endocrinol. Metab. 69, 852–859.
Wood, W., Cachianes, G., Henzel, W., Winslow, G., Spencer, S., Hellmiss, R., Martin, J., and Baxter, R. (1988).Mol. Endocrinol. 2(12), 1176–1185.
Shimasaki, S., Shimonaka, M., Zhang, H.-P., and Ling, N. (1991).J. Biol. Chem. 266(16), 10,646–10,653.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hwa, V., Oh, Y. & Rosenfeld, R.G. Insulin-like growth factor binding protein-3 and-5 are regulated by transforming growth factor-β and retinoic acid in the human prostate adenocarcinoma cell line PC-3. Endocr 6, 235–242 (1997). https://doi.org/10.1007/BF02820498
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02820498